SEC Filing Summary: Croff Enterprises, Inc. (10-Q)
Business Context and Reporting Period
This Form 10-Q covers the quarterly and nine-month periods ended September 30, 2003. The registrant is Croff Enterprises, Inc., an oil and gas exploration and production company based in Denver, Colorado. The filing includes unaudited financial statements and management discussion regarding operations, liquidity, and capital resources. Note: The request metadata referenced "Therapeuticsmd, Inc.," but the source text explicitly identifies the registrant as Croff Enterprises, Inc.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2003 | Nine Months Ended Sep 30, 2003 |
|---|---|---|
| Total Revenues | $115,411 | $311,241 |
| Oil and Gas Sales | $90,612 | $315,289 |
| Net Income | $42,226 | $65,622 |
| Net Income (Common Shares) | $5,766 | $6,785 |
| EPS (Basic & Diluted) | $0.01 | $0.01 |
| Cash from Operations | N/A | $93,003 |
| Working Capital | $378,889 | $378,889 |
| Current Ratio | 15:1 | 15:1 |
| Debt Outstanding | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 42% in the third quarter and 40% for the nine-month period compared to 2002. Oil and gas sales rose 21% (Q3) and 66% (9-month), driven by higher commodity prices and increased production from new wells in Michigan, Montana, Oklahoma, and Texas.
- Commodity Prices: Average oil sales price increased to $27.46/barrel (from $24.58), and natural gas increased to $4.45/Mcf (from $2.25).
- Expense Increases: Lease operating expenses rose significantly due to new acquisitions and higher production taxes. General and administrative expenses increased by $12,353 for the nine-month period, largely due to Sarbanes-Oxley compliance costs.
- Unusual Items: Net income growth for the nine-month period (4%) lagged revenue growth due to a $27,177 unrealized loss on natural gas "put" contracts and $13,787 in costs for a proposed drilling fund. Conversely, a $19,450 gain on the sale of marketable equity securities boosted Q3 net income.
Guidance, Outlook, and Risks
Liquidity and Capital: The company reported no short-term or long-term debt. Management believes operating cash flows and cash on hand ($263,099) are sufficient to cover working capital for the next 12 months. Future capital expenditures will be financed through internal cash flow, asset sales, or potential debt/equity offerings.
Outlook: The company is uncertain regarding the size of its 2004 capital budget. It plans to utilize a proposed drilling fund for development in DeWitt County, Texas.
Risks and Contingencies:
- Commodity Price Volatility: Results are highly dependent on oil and gas prices, which are subject to significant fluctuation.
- Derivative Exposure: The company holds natural gas "put" contracts with a maximum financial exposure of $58,041. These are not accounted for as hedges because the contract volume exceeds current production.
- Reserve Estimates: Significant uncertainties exist regarding the estimation of proved reserves and future production rates.
Investor Verification Checklist
- Verify the discrepancy between the request metadata ("Therapeuticsmd, Inc.") and the actual filing registrant ("Croff Enterprises, Inc.").
- Confirm the impact of the $27,177 loss on natural gas "put" contracts on the nine-month net income.
- Assess the sustainability of the 66% increase in oil and gas sales given the reliance on commodity price increases.
- Review the status of the proposed drilling fund and the $135,473 spent on property leases and improvements.
- Monitor the company's ability to finance future capital expenditures without external debt, given the lack of current debt and reliance on internal cash flow.